Related Experiment Video
Updated: Sep 12, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
KRAS Q61 NSCLC: When Alleles Matter
Marco Meazza Prina1, Laura Mezquita1
1Hospital Clínic de Barcelona Barcelona (Spain) Spain.
Abstract:
A recent article provides the largest characterization to date of KRAS Q61-mutant NSCLC. The findings reveal clinically relevant differences between Q61 alleles and highlight the importance of interpreting KRAS mutations within their genomic context. As RAS-directed therapies evolve, understanding this heterogeneity becomes increasingly relevant for patient stratification and therapeutic development.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene
Ras is a superfamily...
Abnormal Proliferation
Cancers Originate from Somatic Mutations in a Single Cell

